Regulations.gov document
S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International…
Notice · FDA-2021-D-0669 · posted Oct 5, 2021
Key facts
| Document ID | FDA-2021-D-0669-0001 |
|---|---|
| Title | S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International Council for Harmonisation; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2021-D-0669 |
| Posted | Oct 5, 2021 |
| Federal Register citation | 86 FR 54982 |
| FR document number | 2021-21692 |
| Comment period opens | Oct 5, 2021 |
| Comments due | Dec 7, 2021 |
| Effective date | Oct 5, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: